← Back to Search

Oculus Virtual Reality for Virtual Reality (VIP Trial)

N/A
Waitlist Available
Led By Anton Chau, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Indications for hysteroscopy under RN-provided sedation
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45 minutes throughout the operation
Awards & highlights

VIP Trial Summary

Virtual Reality to Improve Satisfaction in Hysteroscopy Patients

Eligible Conditions
  • Virtual Reality
  • Patient Satisfaction
  • Hysteroscopy

VIP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

VIP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes before operation (one anxiety score). 15 minutes after operation (one anxiety score). on a 10 point likert anxiety scale (0-10) high scores are more anxious and low scores are less anxious.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes before operation (one anxiety score). 15 minutes after operation (one anxiety score). on a 10 point likert anxiety scale (0-10) high scores are more anxious and low scores are less anxious. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Satisfaction
Secondary outcome measures
Immersion perception score of the VR system
Incidence of desaturation
Incidence of early termination of VR experience
+5 more
Other outcome measures
Reason for early termination of VR experience

VIP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VR GroupExperimental Treatment1 Intervention
The patient wears the VR headset after being positioned on the table and the surgical time out has been completed. The VR scene and accompanying music will continue until the end of the procedure or until the patient wishes for it to be removed. The patient will receive standard operative and nursing care. The study team member will record the intra-operative vitals as detailed in the control group procedure. At the end of the procedure, the patient will be moved to recovery and will receive standard care. At 15 minutes, they will be provided with the anxiety questionnaire and the ISAS. Additional questions will be asked; their level of VR immersion and if they would like to receive the VR technology again if they were to undergo another procedure in the future. They will then be free to leave once they have met the standard discharge criteria.
Group II: ControlActive Control1 Intervention
The patient will be positioned on the operating table and have routine monitoring attached (ECG, blood pressure, O2 saturations, end tidal carbon dioxide monitoring (ETCO2). A surgical safety time out will be performed. The patient will receive routine operative and nursing care. The study team member will record highest and lowest heart rate and blood pressure as well as lowest O2 saturation and the total intra-operative dose of fentanyl and midazolam administered to the patient. At the end of the procedure, the patient is assisted into a wheelchair and will return to the recovery area. After 15 minutes of recovery, a member of the study team will give them the post-operative questionnaires which will consist of answering how anxious they felt during the procedure and the 11 question Iowa Satisfaction with Anesthesia scale (ISAS). The patient will then be free to leave once they have met the standard discharge criteria.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,411 Previous Clinical Trials
1,766,489 Total Patients Enrolled
1 Trials studying Virtual Reality
89 Patients Enrolled for Virtual Reality
Anton Chau, MDPrincipal InvestigatorUniversity of British Columbia
4 Previous Clinical Trials
273 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~48 spots leftby Apr 2025